 necrosis following high-concentration sclerotherapy for varicose veins. Dermatol
Surg 2000;26:535-41.

Gloviczki et al 47S

319. Ceulen RP, Sommer A, Vernooy K. Microembolism during foam
sclerotherapy of varicose veins. N Engl J Med 2008;358:1525-6.
320. Munavalli GS, Weiss RA. Complications of sclerotherapy. Semin Cutan Med Surg 2007;26:22-8.
321. Bush RG, Derrick M, Manjoney D. Major neurological events following foam sclerotherapy. Phlebology 2008;23:189-92.
322. Picard C, Deltombe B, Duru C, Godefroy O, Bugnicourt JM. Foam
sclerotherapy: a possible cause of ischaemic stroke? J Neurol Neurosurg, Psychiatry 2010;81:582-3.
323. Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose
vein foam injection sclerotherapy. J Vasc Surg 2006;43:162-4.
324. Morrison N, Cavezzi A, Bergan J, Partsch H. Regarding Stroke after
varicose vein foam injection sclerotherapy. J Vasc Surg 2006;44:
224-5.
325. Wright D, Gobin JP, Bradbury AW, Coleridge-Smith P, Spoelstra H,
Berridge D, et al. Varisolve polidocanol microfoam compared with
surgery or sclerotherapy in the management of varicose veins in the
presence of trunk vein incompetence: European randomized controlled trial. Phlebology 2006;21:180-90.
326. Regan JD, Gibson KD, Rush JE, Shortell CK, Hirsch SA, Wright DD.
Clinical significance of cerebrovascular gas emboli during polidocanol
endovenous ultra-low nitrogen